Medical Devices
Hydromer, Inc. Announces Preliminary Financial Results for Q2 2025
Hydromer, Inc. reports a 14% revenue increase in Q2 2025 despite a net loss, highlighting strategic investments for future growth in the medical device sector.
Vycor Medical Reports Significant Growth in Revenue and Operating Profit for First Half of 2025
Vycor Medical, Inc. announces a notable increase in revenue and operating profit for the first six months of 2025, driven by international expansion and advancements in its neurosurgical and vision rehabilitation technologies.
OxyEdge™ 2.0 ATA Sitting Hard Shell Hyperbaric Chamber Introduces a New Standard in Hyperbaric Oxygen Therapy
The OxyEdge™ 2.0 ATA Sitting Hard Shell Hyperbaric Chamber revolutionizes hyperbaric oxygen therapy with its advanced technology, comfort, and affordability, making it accessible for both home and clinical use.
SOBRsafe Inc. Secures European Patent for Innovative Alcohol Detection Technology
SOBRsafe Inc. has been granted a European patent for its SOBRcheck device, marking a significant advancement in noninvasive alcohol monitoring technology with implications for workplace safety and judicial compliance.
HeartBeam Inc.'s FDA-Cleared System Revolutionizes Cardiac Care with Portable Technology
HeartBeam Inc.'s innovative, FDA-cleared portable ECG system marks a significant advancement in cardiac care by enabling arrhythmia monitoring outside traditional clinical settings.
HeartBeam Inc. Strengthens Cardiac Diagnostics with Two New U.S. Patents
HeartBeam Inc. has secured two new U.S. patents, enhancing its cardiac monitoring technology and intellectual property portfolio, marking a significant step forward in portable and accurate heart health diagnostics.
TG Orthodontics Introduces Lightforce Braces for Customized Smile Transformations
TG Orthodontics in Marlboro Township now offers Lightforce braces, a customizable and efficient orthodontic solution that enhances smiles and boosts confidence for patients of all ages.
Former ENT&A CEO Bob Glazer Joins Prosidio as Strategic Advisor to Enhance Endoscopy Accessibility
Bob Glazer, former CEO of ENT and Allergy Associates, joins Prosidio as a strategic advisor to help expand access to affordable, high-quality endoscopy technology for outpatient practices.
United Health Products Awaits FDA Response on Regulatory Hurdles
United Health Products, Inc. faces regulatory challenges with the FDA over its Investigational Device Exemption application and a 2015 Warning Letter, impacting its path to market for its hemostatic gauze product.
HeartBeam Inc. to Discuss Q2 Results and Business Updates in August Conference Call
HeartBeam Inc. (NASDAQ: BEAT) is set to discuss its second-quarter results and provide updates on regulatory initiatives and commercial-readiness activities during a conference call on August 13, 2025, highlighting its progress in transforming cardiac care with innovative technology.
Izotropic Corp. Advances Breast Cancer Imaging with Exclusive Breast CT Technology
Izotropic Corp. is pioneering a patient-centric alternative to mammography for dense breast tissue imaging, with exclusive global rights to Breast CT technology and upcoming U.S. clinical trials.
NanoCell Therapeutics' NCtx Platform Could Revolutionize CAR-T Therapy Accessibility
NanoCell Therapeutics' research demonstrates a novel method for in vivo CAR-T cell generation, potentially reducing costs and increasing access to life-saving cancer treatments.
Xtant Medical Collaborates with B2i Digital to Highlight Orthobiologics Innovation to Investors
Xtant Medical's partnership with B2i Digital aims to educate investors on its orthobiologics platform and market potential, showcasing its growth in the medical technology sector.
GeoVax Explores Needle-Free Vaccine Delivery with Vaxxas Technology
GeoVax Labs, Inc. initiates a research program to evaluate the potential of a needle-free, self-administered GEO-MVA vaccine using Vaxxas' HD-MAP technology, aiming to enhance global immunization efforts.
Roth Capital Partners Facilitates CapsoVision's $27.5 Million IPO
CapsoVision, Inc. successfully launched its initial public offering with Roth Capital Partners as joint book-running manager, marking a significant milestone for the AI-powered medical technology sector.
HeartBeam Inc. Honored with 2025 Innovation Award for Pioneering Remote Cardiac Diagnostics
HeartBeam Inc. (NASDAQ: BEAT) has been awarded the 2025 Innovation Award in Remote Cardiac Diagnostics for its FDA-cleared 3D ECG technology, marking a significant advancement in non-clinical cardiac care.
Shoulder Innovations Secures $40 Million in Financing to Advance Shoulder Surgical Care
Shoulder Innovations has closed a $40 million convertible notes financing to further commercialize its advanced implant systems for shoulder arthroplasty, aiming to improve surgical outcomes and efficiency.
Diopter Technologies Advances Ocular Disease Treatment with Dissolving Contact Lens
Diopter Technologies has completed early clinical studies for a dissolving amniotic membrane biopolymer contact lens, offering a novel approach to treating ocular surface diseases by delivering growth factors directly to the eye.
Lorati's Nano-Emulsion Offers New Hope for Stroke Recovery
Lorati Co., Ltd. introduces a natural, mineral-based nano-emulsion therapy that promises a non-invasive solution for full recovery from both hemorrhagic and ischemic strokes, marking a significant advancement in stroke treatment.
SeaStar Medical's QUELIMMUNE Recognized by National Kidney Foundation for Innovation in Pediatric AKI Treatment
SeaStar Medical's QUELIMMUNE device, designed to treat pediatric acute kidney injury, has been awarded the 2025 Corporate Innovator Award by the National Kidney Foundation, highlighting its potential to significantly reduce mortality rates and improve quality of life for affected children.
Intelligent Bio Solutions Inc. to Showcase Fingerprint Sweat PK Study at ADLM 2025 Clinical Lab Expo
Intelligent Bio Solutions Inc. will present its pharmacokinetic study data at the ADLM 2025 Clinical Lab Expo, highlighting the reliability of fingerprint sweat as a non-invasive diagnostic tool for drug screening.
Somnair Secures $4.3M Seed Funding for Innovative Sleep Apnea Device
Somnair, founded by Johns Hopkins alumni, has raised $4.3 million to develop a non-invasive device for obstructive sleep apnea, addressing a significant unmet need for patients intolerant to traditional CPAP therapy.
HeartBeam Inc. (NASDAQ: BEAT) Pioneers At-Home Cardiac Care with Innovative ECG Technology
HeartBeam Inc. is revolutionizing cardiac care with its at-home detection and monitoring technology, offering a potential shift in how cardiac conditions are managed outside traditional medical settings.
Plexāā Secures $4.5 Million to Launch Innovative Breast Surgery Device in the U.S.
Plexāā's recent funding extension underscores the potential of its BLOOM⁴³ device to revolutionize breast surgery outcomes by reducing complications through Supraphysiological Preconditioning.
MS Tech Secures $1.2M R&D Grant for Early Disease Detection Biosensors
MS Tech Ltd. has been awarded a $1.2M R&D grant by the Israel Innovation Authority to advance its innovative biosensor technology for early disease screening and biomarkers diagnostics, marking a significant step forward in point-of-care diagnostics.
Prosidio Endoscope Facilitates Historic Endoscopic Pituitary Surgery in The Gambia
The first-ever endoscopic pituitary surgery in The Gambia, enabled by Prosidio's advanced endoscope, marks a significant advancement in neurosurgical care for the region.
SeaStar Medical's QUELIMMUNE Shows Promise in Treating Pediatric AKI
SeaStar Medical's QUELIMMUNE device, approved by the FDA, significantly reduces mortality rates in pediatric patients with acute kidney injury (AKI) by targeting the cytokine storm at its source.
SeaStar's QUELIMMUNE Shows Promise in Halving Pediatric Sepsis Mortality Rates
SeaStar Medical's QUELIMMUNE therapy, approved by the FDA in 2024, has demonstrated the potential to reduce pediatric sepsis mortality rates by half, offering hope for critically ill children with acute kidney injury.
Medicus Pharma Ltd. Develops Novel Non-Invasive Treatment for Basal Cell Carcinoma
Medicus Pharma Ltd. is advancing a revolutionary, non-invasive microneedle patch treatment for basal cell carcinoma, potentially transforming the $15 billion skin cancer treatment market.
HeartBeam Inc. to Showcase Innovations at iAccess Alpha Virtual Summer Conference
HeartBeam Inc. (NASDAQ: BEAT) will present its advancements in personalized cardiac care at the iAccess Alpha Virtual Best Ideas Summer Conference, highlighting its potential to redefine cardiac health management.